Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
September 12, 2018
CIDARA THERAPEUTICS APPOINTS DAVID GOLLAHER, PH.D., TO BOARD OF DIRECTORS
September 10, 2018
BIODESY ANNOUNCES NEW CEO AND $20 MILLION SERIES C FINANCING TO ACCELERATE EXPANSION INTO BIOTHERAPEUTICS DISCOVERY AND DEVELOPMENT MARKET
September 10, 2018
Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology
August 21, 2018
Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy
August 10, 2018
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
August 9, 2018
Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 9, 2018
CIDARA PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
August 7, 2018
AKOUOS RAISES $50 MILLION SERIES A FINANCING AND EXPANDS TEAM TO ADVANCE PRECISION GENETIC THERAPIES THAT RESTORE AND PRESERVE HEARING
August 7, 2018
Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy
August 7, 2018
Nohla Therapeutics Receives FDA Fast Track Designation for Dilanubicel for Allogeneic Cord Blood Transplant Patients
« Previous Page
1
2
3
4
5
6
…
10
Next Page »